
    
      The investigators are undertaking a parallel group, multicentre, randomised controlled trial
      of 300 adults with ITP from 11 medical centers in China. Part of the participants are
      randomly selected to receive high-dose dexamethasone treatment and the other part are
      selected to receive conventional dose of prednisone treatment. Platelet count, bleeding and
      other symptoms were evaluated before and after treatment. Adverse events are also recorded
      throughout the study. In order to report the efficacy and safety of high-dose dexamethasone
      compared to conventional dose prednisone for the first-line treatment of adults with ITP.
    
  